<p>UG, LIPUS treatment group; UAG, LIPUS treatment plus AMD3100 treatment group; CG, control group received sham treatment, Cl.Ar, total callus area; Cg.Ar, cartilage area; Cg.Ar/Cl.Ar, the percentage of cartilage area.</p>a<p>p = 0.038 between UG and CG.</p><p>Histomorphometric analysis of femoral microarchitecture at week 4 post-fracture.</p
<p>(A) Cartilage volume. (B) Cartilage surface area. (C) Average cartilage thickness. (D) Bone volum...
<p>All data are given as means±SD. * P<0.05 versus corresponding values of the vehicle-treated contr...
<p>Original magnifications: e, f: ×10; g, h: ×20; c, d: ×100; a, b: ×200. Cg, cartilage callus; Wb, ...
<p>WT: white columns, <i>Fzd9</i><sup>−/−</sup>: grey columns. All values are presented as median, i...
<p>For histological analysis, mid-sagittal sections of fractured femora were stained with Safranin O...
<p>(A) Femur sections from control group at 0, 4 and 8 weeks after the primary injection. (B) Femur ...
<p>Histomorphometric quantification of cartilage area (<b>A</b>) and fracture callus areas (<b>B</b>...
<p>BMD, bone mineral density (mg/cm<sup>3</sup>), refers to the total BMD of the ROI; BMC, bone mine...
<p><b>(A)</b> Representative H&E staining images of calvarial bone sections from each group: Control...
<p>(A) Microphotographs of ALP-positive cells at the damaged site on day 7 after a femoral bone defe...
<p>BMD, bone mineral density (mg/cm<sup>3</sup>), refers to the total BMD of the ROI; BMC, bone mine...
<p>(<b>A</b>) Representative 3D reconstructed micro-CT images of the three groups at week 4 post-fra...
<p>Histomorphometry data of the total periosteal callus in mm<sup>2</sup>, the relative bone area, t...
<p>µCT analysis of (a) Percentage of Bone volume/Tissue volume, (b) Trabecular thickness, (c) Struct...
SummaryObjectiveCurrent histological scoring methods to evaluate efficacy of potential therapeutics ...
<p>(A) Cartilage volume. (B) Cartilage surface area. (C) Average cartilage thickness. (D) Bone volum...
<p>All data are given as means±SD. * P<0.05 versus corresponding values of the vehicle-treated contr...
<p>Original magnifications: e, f: ×10; g, h: ×20; c, d: ×100; a, b: ×200. Cg, cartilage callus; Wb, ...
<p>WT: white columns, <i>Fzd9</i><sup>−/−</sup>: grey columns. All values are presented as median, i...
<p>For histological analysis, mid-sagittal sections of fractured femora were stained with Safranin O...
<p>(A) Femur sections from control group at 0, 4 and 8 weeks after the primary injection. (B) Femur ...
<p>Histomorphometric quantification of cartilage area (<b>A</b>) and fracture callus areas (<b>B</b>...
<p>BMD, bone mineral density (mg/cm<sup>3</sup>), refers to the total BMD of the ROI; BMC, bone mine...
<p><b>(A)</b> Representative H&E staining images of calvarial bone sections from each group: Control...
<p>(A) Microphotographs of ALP-positive cells at the damaged site on day 7 after a femoral bone defe...
<p>BMD, bone mineral density (mg/cm<sup>3</sup>), refers to the total BMD of the ROI; BMC, bone mine...
<p>(<b>A</b>) Representative 3D reconstructed micro-CT images of the three groups at week 4 post-fra...
<p>Histomorphometry data of the total periosteal callus in mm<sup>2</sup>, the relative bone area, t...
<p>µCT analysis of (a) Percentage of Bone volume/Tissue volume, (b) Trabecular thickness, (c) Struct...
SummaryObjectiveCurrent histological scoring methods to evaluate efficacy of potential therapeutics ...
<p>(A) Cartilage volume. (B) Cartilage surface area. (C) Average cartilage thickness. (D) Bone volum...
<p>All data are given as means±SD. * P<0.05 versus corresponding values of the vehicle-treated contr...
<p>Original magnifications: e, f: ×10; g, h: ×20; c, d: ×100; a, b: ×200. Cg, cartilage callus; Wb, ...